Study: Men with CDK12 mutation may be... - Advanced Prostate...

Advanced Prostate Cancer

21,584 members27,020 posts

Study: Men with CDK12 mutation may benefit from checkpoint immunotherapy

johngwilk profile image
1 Reply

"CDK12-mutant tumors were completely unique from all other prostate cancer subtypes, including those with MMR mutations. CDK12-mutant tumors expressed a unique set of genes, and had a unique pattern of mutations, including a high level of mutations that altered the form of proteins. This finding led DR. Chinnaiyan and team to hypothesize that these tumors may be visible as “bad apples” to the immune system – and that immunotherapy may work for these patients."

EDIT: About 6% of men with advanced PCa have the CDK12 mutation.

Written by
johngwilk profile image
johngwilk
To view profiles and participate in discussions please or .
Read more about...
1 Reply
CantChoose profile image
CantChoose

Thanks - - so interesting.

I've read now in one article that there are six PC subtypes; in another that it's 16. I realize the science is too young for standardization, but is there any emerging consensus on subtypes?

Do any board denizens know their own subtype?

Not what you're looking for?

You may also like...

CDK 12 mutation and Immunotherapy

is starting to rise on Arbi/Dexa. I have the CDK12 mutation which is apparently known to be a drug...

looking for members with CDK12 mutations.

treatment plans & outcomes for those men who harbor the CDK12 mutation. I know of two but can’t...

Who here is on Keytruda or other checkpoint inhibitor or some kind of immunotherapy?

am on a bunch of other stuff including dendritic cell vaccine immunotherapy. My onco doesn’t want...

Has anyone used CheckPoint Immunotherapy?

are rising so its either Chemotherapy or an Immunotherapy called Checkpoint has anyone heard of it?...

Clinical trial / study: BRCA mutations

Avelumab (Immunotherapy, Checkpoint inhibitor). Supposedly lab tests showed that there may be a...